Clinical Trial: Safety and Efficacy of HPP737 in Adult Patients With Plaque Psoriasis

U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07707141) titled 'Safety and Efficacy of HPP737 in Adult Patients With Plaque Psoriasis' on July 06.

Brief Summary: The goal of this clinical trial is to learn if drug HPP737 works to treat moderate-to-severe plaque psoriasis in adults. It will also learn about the safety of drug HPP737. The main questions it aims to answer are:

Does drug HPP737 improve psoriasis severity compared to placebo, as measured by the proportion of patients achieving at least a 75% improvement in the Psoriasis Area and Severity Index (PASI 75) at Day 85? What medical problems do participants have when taking drug HPP737? Researchers will compare drug HPP737 to a placebo (a...